Related Experiment Videos
Hypoxia and VEGF mRNA expression in human tumors
L S Ziemer1, C J Koch, A Maity
1School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Summary
Hypoxia, or low oxygen, in tumors is linked to vascular endothelial growth factor (VEGF) expression, a marker of poor cancer treatment response. This study confirms their co-localization in human tumors, supporting their biological connection.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- High plasma vascular endothelial growth factor (VEGF) correlates with poor cancer treatment outcomes.
- Tumor hypoxia is a predictor of treatment failure, potentially linked to VEGF expression.
- Previous studies showed indirect or negative correlations between tumor hypoxia and VEGF in humans.
Purpose of the Study:
- To directly assess the relationship between hypoxia and VEGF expression in human tumors.
- To investigate if VEGF mRNA and hypoxia markers colocalize within tumor tissues.
- To explore factors influencing the hypoxia-VEGF link in human cancers.
Main Methods:
- Direct assessment of VEGF mRNA using in situ hybridization.
- Measurement of tumor hypoxia via EF5 adduct distribution.
- Analysis of blood vessel distribution using CD31 antibodies.
- Comparison of marker distributions in human tumor samples (squamous cell carcinomas, sarcomas, glioblastoma).
Main Results:
- VEGF mRNA maxima colocalized with hypoxia marker (EF5) maxima where detectable.
- Strongest signals for both markers were sometimes near necrotic regions.
- Low hypoxia regions consistently showed low or undetectable VEGF mRNA.
- Absolute levels of hypoxia could not be predicted by VEGF mRNA levels alone.
Conclusions:
- The data support the paradigm linking tumor hypoxia and VEGF expression in human tumors.
- Understanding the hypoxia-VEGF biology is crucial for optimizing VEGF as a prognostic indicator.
- Further research can inform biologic therapies targeting VEGF modulation in cancer.